Peey-Sei Kok Clinical Oncology Society of Australia Annual Scientific Meeting 2018

Abstracts this author is presenting:

• DREAM - A phase 2 trial of DuRvalumab with first line chEmotherApy in Mesothelioma: Final result — Best of the Best Orals - Clinical research featuring Mesothelioma